Related Experiment Video
Updated: Dec 27, 2025

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane
Beiyu Tang1,2, Xue Li1,3, Thorsten Maretzky4
1Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY, USA.
Abstract:
The metalloprotease ADAM17 (a disintegrin and metalloprotease 17) regulates EGF-receptor and TNFα signaling, thereby not only protecting the skin and intestinal barrier, but also contributing to autoimmunity. ADAM17 can be rapidly activated by many stimuli through its transmembrane domain (TMD), with the seven membrane-spanning inactive Rhomboids (iRhom) 1 and 2 implicated as candidate regulatory partners. However, several alternative models of ADAM17 regulation exist that do not involve the iRhoms, such as regulation through disulfide bond exchange or through interaction with charged phospholipids. Here, we report that a non-activatable mutant of ADAM17 with the TMD of betacellulin (BTC) can be rescued by restoring residues from the ADAM17 TMD, but only in Adam17-/- cells, which contain iRhoms, not in iRhom1/2-/- cells. We also provide the first evidence that the extracellular juxtamembrane domains (JMDs) of ADAM17 and iRhom2 regulate the stimulation and substrate selectivity of ADAM17. Interestingly, a point mutation in the ADAM17 JMD identified in a patient with Tetralogy of Fallot, a serious heart valve defect, affects the substrate selectivity of ADAM17 toward Heparin-binding epidermal growth factor like growth factor (HB-EGF), a crucial regulator of heart valve development in mice. These findings provide new insights into the regulation of ADAM17 through an essential interaction with the TMD1 and JMD1 of iRhom2.
Insights
The metalloprotease ADAM17 (a disintegrin and metalloprotease 17) requires iRhom2 for activation, and its juxtamembrane domains regulate substrate selectivity, impacting conditions like Tetralogy of Fallot.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- ADAM17 (a disintegrin and metalloprotease 17) is a key regulator of EGF-receptor and TNFα signaling, crucial for barrier integrity and implicated in autoimmunity.
- ADAM17 activation is linked to its transmembrane domain (TMD) and potential partners like inactive Rhomboids (iRhoms).
- Alternative models for ADAM17 regulation exist, independent of iRhoms.
Purpose of the Study:
- To investigate the role of iRhoms in ADAM17 activation and regulation.
- To explore the function of juxtamembrane domains (JMDs) in ADAM17 substrate selectivity.
- To examine the impact of ADAM17 mutations on specific signaling pathways and developmental processes.
Main Methods:
- Utilized a non-activatable ADAM17 mutant with a betacellulin (BTC) TMD.
- Employed knockout cell lines (Adam17-/- and iRhom1/2-/-) to assess iRhom dependency.
- Analyzed the effects of mutations in ADAM17 and iRhom2 JMDs on ADAM17 activity and substrate preference.
Main Results:
- ADAM17 activation by its TMD is dependent on the presence of iRhoms.
- The extracellular JMDs of ADAM17 and iRhom2 were shown to regulate ADAM17 stimulation and substrate selectivity.
- A patient-derived mutation in the ADAM17 JMD altered its selectivity towards HB-EGF, a critical factor in heart valve development.
Conclusions:
- ADAM17 activation is critically dependent on an interaction with iRhom2.
- The JMDs of ADAM17 and iRhom2 play essential roles in modulating ADAM17 function and substrate targeting.
- Findings provide insights into ADAM17 regulation and its link to congenital heart defects like Tetralogy of Fallot.
More Related Videos
Related Concept Videos
Export of Misfolded Proteins out of the ER
Insertion of Single-pass Transmembrane Proteins in the RER
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
Post-translational Translocation of Proteins to the RER
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...

